Evolent Health (EVH) Return on Capital Employed (2015 - 2026)

Evolent Health's Return on Capital Employed history runs 12 years deep, the most recent figure standing at 27.8% for Q1 2026.

• On a quarterly basis, Return on Capital Employed fell 2625.0% year-over-year to 27.8% in Q1 2026; TTM through Mar 2026 was 27.8%, a 2625.0% decrease from a year earlier, with the FY2025 full-year figure at 22.33%, down 2020.0% from the prior year.
• Return on Capital Employed fell to 27.8% in Q1 2026 per EVH's latest filing, from 22.9% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 0.27% in Q4 2022 and bottomed at 27.8% in Q1 2026.
• The 5-year median for Return on Capital Employed is 2.2% (2024), against an average of 4.63%.
• Across the five-year window, Return on Capital Employed surged 2452 bps in 2022 and slumped 2625 bps in 2026, its largest moves.
• Year by year, Return on Capital Employed stood at 0.27% in 2022, then plunged by 1424 bps to 3.56% in 2023, then surged by 37 bps to 2.24% in 2024, then slumped by 922 bps to 22.9% in 2025, then declined by 21 bps to 27.8% in 2026.
• Per Business Quant, the three latest EVH Return on Capital Employed figures stand at 27.8% (Q1 2026), 22.9% (Q4 2025), and 1.01% (Q3 2025).